Research output: Contribution to journal › Article › peer-review
The ability of the antitumor analogs of luliberin (LH-RH), a hypothalamic peptide hormone, to stimulate the immune function of T cells is examined in experiments with the gene coding for interleukin-2 (IL-2). Recombinant MIL2C or 4xPu DNA containing the marker gene of chloramphenicol acetyltransferase (CAT) under the control of a 2.2 kb promoter of murine IL-2 gene or four copies of purine-rich element (from -292 to -246 base pairs), respectively, is injected in Xenopus laevis oocytes. The promoter activity is blocked by inoculation of the protein fraction of nuclear extracts from resting mouse splenic T cells. The IL-2 gene promoter is dereppressed after injection of the short LH-RH analog L1 (7 amino acid residues) into the oocyte nucleus or cytoplasm. The addition of L1 or L2 (an LH-RH analog consisting of 10 amino acid residues) to the incubation medium activates mouse splenic T cells and stimulates the synthesis of IL-2 mRNA 2-to 3-fold more intensely than ConA+rIL-2, judging from dot-blot and in situ hybridization data. Cytological analysis of cell culture shows that the presence of L1 and L2 peptides in the culture medium promotes differentiation of T cells. It is hypothesized that the antitumor activity of these peptides is associated with the stimulation of IL-2 synthesis.
Translated title of the contribution | Биологическая активность аналогов пептидного гормона - люлиберина в регуляции иммунного ответа Т-лимфоцитов |
---|---|
Original language | English |
Pages (from-to) | 943-946 |
Number of pages | 4 |
Journal | Bulletin of Experimental Biology and Medicine |
Volume | 122 |
Issue number | 9 |
State | Published - 1 Sep 1996 |
ID: 41855264